
CORZ Valuation
Core Scientific Inc
CORZ Relative Valuation
CORZ's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, CORZ is overvalued; if below, it's undervalued.
Historical Valuation
Core Scientific Inc (CORZ) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -152.37. The fair price of Core Scientific Inc (CORZ) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price:14.73
Fair
-88.52
PE
1Y
3Y
5Y
Trailing
Forward
20.43
EV/EBITDA
Core Scientific Inc. (CORZ) has a current EV/EBITDA of 20.43. The 5-year average EV/EBITDA is 17.13. The thresholds are as follows: Strongly Undervalued below 5.10, Undervalued between 5.10 and 11.11, Fairly Valued between 23.14 and 11.11, Overvalued between 23.14 and 29.15, and Strongly Overvalued above 29.15. The current Forward EV/EBITDA of 20.43 falls within the Historic Trend Line -Fairly Valued range.
-139.21
EV/EBIT
Core Scientific Inc. (CORZ) has a current EV/EBIT of -139.21. The 5-year average EV/EBIT is 16.06. The thresholds are as follows: Strongly Undervalued below -219.08, Undervalued between -219.08 and -101.51, Fairly Valued between 133.62 and -101.51, Overvalued between 133.62 and 251.19, and Strongly Overvalued above 251.19. The current Forward EV/EBIT of -139.21 falls within the Undervalued range.
6.78
PS
Core Scientific Inc. (CORZ) has a current PS of 6.78. The 5-year average PS is 5.26. The thresholds are as follows: Strongly Undervalued below 0.24, Undervalued between 0.24 and 2.75, Fairly Valued between 7.78 and 2.75, Overvalued between 7.78 and 10.29, and Strongly Overvalued above 10.29. The current Forward PS of 6.78 falls within the Historic Trend Line -Fairly Valued range.
18.60
P/OCF
Core Scientific Inc. (CORZ) has a current P/OCF of 18.60. The 5-year average P/OCF is 15.50. The thresholds are as follows: Strongly Undervalued below 0.57, Undervalued between 0.57 and 8.04, Fairly Valued between 22.96 and 8.04, Overvalued between 22.96 and 30.43, and Strongly Overvalued above 30.43. The current Forward P/OCF of 18.60 falls within the Historic Trend Line -Fairly Valued range.
35.65
P/FCF
Core Scientific Inc. (CORZ) has a current P/FCF of 35.65. The 5-year average P/FCF is -5.54. The thresholds are as follows: Strongly Undervalued below -106.40, Undervalued between -106.40 and -55.97, Fairly Valued between 44.89 and -55.97, Overvalued between 44.89 and 95.31, and Strongly Overvalued above 95.31. The current Forward P/FCF of 35.65 falls within the Historic Trend Line -Fairly Valued range.
Core Scientific Inc (CORZ) has a current Price-to-Book (P/B) ratio of -4.03. Compared to its 3-year average P/B ratio of -5.03 , the current P/B ratio is approximately -19.86% higher. Relative to its 5-year average P/B ratio of -5.03, the current P/B ratio is about -19.86% higher. Core Scientific Inc (CORZ) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -0.86%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -0.86% , the current FCF yield is about -100.00% lower.
-4.03
P/B
Median3y
-5.03
Median5y
-5.03
-7.32
FCF Yield
Median3y
-0.86
Median5y
-0.86
Competitors Valuation Multiple
The average P/S ratio for CORZ's competitors is 0.00, providing a benchmark for relative valuation. Core Scientific Inc Corp (CORZ) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of -14.95%, this premium appears unsustainable.
Performance Decomposition
1Y
3Y
5Y
Market capitalization of CORZ decreased by 17.62% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -4.29 to -6.85.
The secondary factor is the Revenue Growth, contributed -14.95%to the performance.
Overall, the performance of CORZ in the past 1 year is driven by P/E Change. Which is more unsustainable.
People Also Watch

ASB
Associated Banc-Corp
25.630
USD
+4.10%

AI
C3.ai Inc
13.630
USD
+6.07%

PRCT
Procept Biorobotics Corp
29.860
USD
+7.06%

GSHD
Goosehead Insurance Inc
71.360
USD
+3.65%

IBOC
International Bancshares Corp
66.390
USD
+2.88%

KGS
Kodiak Gas Services Inc
33.490
USD
+0.03%

UNF
UniFirst Corp
163.050
USD
+2.00%

OGS
ONE Gas Inc
82.920
USD
+1.32%

KMPR
Kemper Corp
38.990
USD
+2.26%

AX
Axos Financial Inc
79.470
USD
+3.52%
FAQ
Is Core Scientific Inc (CORZ) currently overvalued or undervalued?
Core Scientific Inc (CORZ) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -152.37. The fair price of Core Scientific Inc (CORZ) is between NaN to NaN according to relative valuation methord.








